E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells

Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification

(2014) Sanaz Tabarestani et al.   CELLULAR ONCOLOGY

Validation of DNA promoter hypermethylation biomarkers in breast cancer — a short report

(2014) Jolien S. de Groot et al.   CELLULAR ONCOLOGY

SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer

(2013) Gopisetty Gopal et al.   Cancer Genetics

Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole

(2013) Akhilesh Rawat et al.   CELLULAR ONCOLOGY

Aberrant promoter CpG methylation and its translational applications in breast cancer

(2011) Ting-Xiu Xiang et al.   Chinese Journal of Cancer

SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer

(2010) Kathryn A. Clausen et al.   BREAST CANCER RESEARCH AND TREATMENT

DNA methylation inhibits p53-mediated survivin repression

(2009) N H Nabilsi et al.   ONCOGENE

A Human Bone Morphogenetic Protein Antagonist Is Down-Regulated in Renal Cancer

(2007) Kimberly Rose Blish et al.   MOLECULAR BIOLOGY OF THE CELL